Research
Hormonal
Insulin resistance in patients with polycystic ovary syndrome (PCOS) is a distinct and significant research hotspot, with metformin and glucose tolerance being key intervention and outcome measures.
For women with PCOS and insulin resistance, clinical trials often focus on metformin administration and improving glucose tolerance. This is a distinct clinical pathway from general obesity-related insulin resistance.
ModerateSupportsMEDIUM confidence
Cluster 3 addressed 'insulin resistance in polycystic ovary syndrome (PCOS).' ... Metformin (101); administration (100); insulin secretion (75); glucose tolerance (73)...
Why this rating
Bibliometric analysis of RCTs.
Source
Mapping the landscape of research on insulin resistance: a visualization analysis of randomized clinical trials
Sa’ed H. Zyoud · Journal of Health Population and Nutrition · 2024
DOI 10.1186/s41043-024-00497-4
narrative_reviewCited 8×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Randomized clinical trials demonstrate that dietary interventions (specifically low-carbohydrate or high-fiber diets) and physical activity significantly improve insulin sensitivity in obese individuals.Moderate
- Utilizing lipid panels (specifically triglycerides and LDL-C levels) serves as a valid clinical indicator for assessing insulin resistance.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →